The effects of furosemide and pentoxifylline on the flow properties of equine erythrocytes: in vitro studies
- PMID: 7863609
- DOI: 10.1007/BF01839288
The effects of furosemide and pentoxifylline on the flow properties of equine erythrocytes: in vitro studies
Abstract
The effects of various concentrations of furosemide and pentoxifylline on equine RBC in vitro were evaluated to facilitate better understanding of the potential effects of these drugs on blood flow properties. Furosemide induced increased mean cell volume (MCV), increased RBC potassium concentration, increased whole blood viscosity, and decreased the RBC filtrability. These data indicate that furosemide may block the RBC membrane transport pathways resulting in potassium and water retention. The increase in size and the resultant decrease in the surface-area-to-volume ratio may have caused the impaired RBC filtrability and increased blood viscosity. Pentoxifylline improved RBC filtrability without changing the RBC size or the potassium or chloride concentrations, suggesting that pentoxifylline may increase the deformability of the RBC membrane. The study indicated that pentoxifylline has potential therapeutic applications for improving microvascular blood flow but that furosemide may have adverse effects on blood flow.
Similar articles
-
Effects of furosemide and pentoxifylline on blood flow properties in horses.Am J Vet Res. 1992 Nov;53(11):2043-9. Am J Vet Res. 1992. PMID: 1466500
-
Effects of furosemide on hemorheologic alterations induced by incremental treadmill exercise in thoroughbreds.Am J Vet Res. 1996 Jun;57(6):891-5. Am J Vet Res. 1996. PMID: 8725819
-
Effects of echinocytosis on hemorrheologic values and exercise performance in horses.Am J Vet Res. 1994 Feb;55(2):204-10. Am J Vet Res. 1994. PMID: 8172408
-
Red blood cell microrheology (clinical and pharmacological applications).Ric Clin Lab. 1983;13 Suppl 3:53-70. Ric Clin Lab. 1983. PMID: 6369496 Review.
-
Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.J Clin Pharmacol. 1985 Jan-Feb;25(1):8-26. doi: 10.1002/j.1552-4604.1985.tb02796.x. J Clin Pharmacol. 1985. PMID: 3882773 Review. No abstract available.